Eli Lilly’s Alzheimer’s Drug Kisunl...

By HEOR Staff Writer

September 30, 2024

Introduction Eli Lilly has achieved a milestone with its Alzheimer's drug Kisunla, recently approved by Japan's health ministry. Donanemab (Kisunla) is an antibody drug designe...
The Effect of Sedentary Behaviour on Healthy Ageing
The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS...
The Readiness of Biosimilars in Multiple Sclerosis Treatment
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depres...
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Elderly Technology Acceptance: Enhancing Health and Independence
A Comparative Study on PRO Symptom Monitoring Approaches
Efficacy of Early Intensive Behavioural Intervention for Autism
Enhancing Patient Care in Oncology through Remote Patient Monitoring
Evaluating AI Systems for Diabetic Retinopathy Screening
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis